KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Treasury Shares (2021 - 2024)

Bionano Genomics' Treasury Shares history spans 5 years, with the latest figure at $3590.0 for Q3 2025.

  • For Q3 2025, Treasury Shares fell 87.62% year-over-year to $3590.0; the TTM value through Sep 2025 reached $3590.0, down 87.62%, while the annual FY2024 figure was $6000.0, 1150.0% up from the prior year.
  • Treasury Shares for Q3 2025 was $3590.0 at Bionano Genomics, down from $5210.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $561000.0 in Q2 2024 and bottomed at $480.0 in Q4 2023.
  • The 5-year median for Treasury Shares is $184000.0 (2024), against an average of $175618.7.
  • The largest annual shift saw Treasury Shares crashed 98.34% in 2023 before it surged 1834.48% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $361000.0 in 2021, then crashed by 91.97% to $29000.0 in 2022, then plummeted by 98.34% to $480.0 in 2023, then surged by 1150.0% to $6000.0 in 2024, then crashed by 40.17% to $3590.0 in 2025.
  • Per Business Quant, the three most recent readings for BNGO's Treasury Shares are $3590.0 (Q3 2025), $5210.0 (Q1 2025), and $6000.0 (Q4 2024).